BOSTON--(BUSINESS WIRE)--MetaStat, Inc. (OTCQB: MTST), a molecular diagnostic company focused on developing and commercializing epigenetic-based diagnostic tests for early and reliable prediction of systemic metastasis, was featured in Medscape.com, WNYM-AM, WHCR-FM and the Boston Business Journal.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
